UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

Bone marrow transplantation (Basingstoke), 2010-10, Vol.45 (10), p.1546-1552

2010

Volltextzugriff (PDF)

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.539-543

2017

Volltextzugriff (PDF)

Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia

Leukemia, 2011-10, Vol.25 (10), p.1661-1664

2011

Volltextzugriff (PDF)

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents

Leukemia, 2013-06, Vol.27 (6), p.1283-1290

2013

Volltextzugriff (PDF)

L-Asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature

Annals of oncology, 2009-01, Vol.20 (1), p.110-116

2009

Volltextzugriff (PDF)

Outcome of Childhood Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid and Chemotherapy

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1404-1412

2004

Volltextzugriff (PDF)

Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD

Bone marrow transplantation (Basingstoke), 2011-10, Vol.46 (10), p.1374-1381

2011

Volltextzugriff (PDF)

OR40: Influence of Gut Health and Macrophages Reactivity before Conditioning Regimen in Acute Graft Versus Host Disease

Clinical nutrition (Edinburgh, Scotland), 2016-09, Vol.35, p.S16-S17

2016

Volltextzugriff (PDF)

Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (11), p.757-760

2008

Volltextzugriff (PDF)

Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes

Current research in translational medicine, 2017-04, Vol.65 (2), p.77-81

2017

Volltextzugriff (PDF)

Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimen

Bone marrow transplantation (Basingstoke), 2014-12, Vol.49 (12), p.1492-1497

2014

Volltextzugriff (PDF)

PO-264 Mitochondrial metabolism: a key factor of myeloid leukemic cell response upon exposure to tyrosine kinase inhibitors

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A123-A124

2018

Volltextzugriff (PDF)

Risk factors for candidemia: a prospective matched case-control study

Critical care (London, England), 2020-03, Vol.24 (1), p.109-109, Article 109

2020

Volltextzugriff (PDF)

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

The New England journal of medicine, 2013-11, Vol.369 (19), p.1783-1796

2013

Volltextzugriff (PDF)

Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Bone marrow transplantation (Basingstoke), 2023-04, Vol.58 (4), p.401-406

2023

Volltextzugriff (PDF)

An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients

Haematologica (Roma), 2006-08, Vol.91 (8), p.1134-1138

2006

Volltextzugriff (PDF)

SUN-PO087: Value of Nutritional Parameters as Predictors of Mortality Within 2 Years After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical nutrition (Edinburgh, Scotland), 2019-09, Vol.38, p.S91-S91

2019

Volltextzugriff (PDF)

The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease

Pathologie biologie (Paris), 2014-06, Vol.62 (3), p.123-128

2014

Volltextzugriff (PDF)

Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC

Pathologie biologie (Paris), 2014-08, Vol.62 (4), p.226-229

2014

Volltextzugriff (PDF)

Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial

Leukemia, 2003-02, Vol.17 (2), p.339-342

2003

Volltextzugriff (PDF)

Inhibiteurs de tyrosine-kinase de 2e génération et associations: perspectives

Oncologie (Paris, France), 2012-10, Vol.14 (10-11), p.601-605

Coiteux, V.

2012

Volltextzugriff (PDF)

Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma

Haematologica (Roma), 2008-12, Vol.93 (12), p.1908-1911

2008

Volltextzugriff (PDF)

Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report

Pathologie biologie (Paris), 2013-08, Vol.61 (4), p.152-154

2013

Volltextzugriff (PDF)

172 Azacytidine in relapsed MDS and AML after allogeneic stem cell transplantation: Results of the French ATU Program

Leukemia research, 2011-05, Vol.35, p.S67-S67

2011

Volltextzugriff (PDF)

Inhibiteurs de tyrosine-kinase de 2e génération et associations: perspectives: Leucémie myéloïde chronique (LMC) en 2012

Oncologie (Paris, France), 2012, Vol.14 (10-11), p.601-605

COITEUX, V

2012

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(27)
Male
(20)
Female
(19)
Middle Aged
(19)
Hematology
(17)
Treatment Outcome
(16)
Adult
(15)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Oncology
(14)
Aged
(13)
Hematologic And Hematopoietic Diseases
(9)
Transplantation
(9)
Adolescent
(8)
Hematology, Oncology And Palliative Medicine
(8)
Immunology
(8)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(8)
Leukemia
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML

Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents

L-Asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature

Outcome of Childhood Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid and Chemotherapy

Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD

OR40: Influence of Gut Health and Macrophages Reactivity before Conditioning Regimen in Acute Graft Versus Host Disease

Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD

Long-term follow up of invasive aspergillosis in allogeneic stem cell transplantation recipients and leukemia patients: Differences in risk factors and outcomes

Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimen

PO-264 Mitochondrial metabolism: a key factor of myeloid leukemic cell response upon exposure to tyrosine kinase inhibitors

Risk factors for candidemia: a prospective matched case-control study

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients

SUN-PO087: Value of Nutritional Parameters as Predictors of Mortality Within 2 Years After Allogeneic Hematopoietic Stem Cell Transplantation

The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease

Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC

Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial

Inhibiteurs de tyrosine-kinase de 2e génération et associations: perspectives

Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma

Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report

172 Azacytidine in relapsed MDS and AML after allogeneic stem cell transplantation: Results of the French ATU Program

Inhibiteurs de tyrosine-kinase de 2e génération et associations: perspectives: Leucémie myéloïde chronique (LMC) en 2012

Suchergebnisse filtern